Intelligent Investor

Universal Biosensors, Inc. (ASX: UBI) - Announcements

- Current share price for UBI : $0.150

ASX company news and announcements for Universal Biosensors, Inc. (UBI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Universal Biosensors, Inc. (UBI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Universal Biosensors, Inc. (UBI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Universal Biosensors, Inc. (UBI)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$35 UBI receives $4,495,137 under the R&D Tax Incentive Rebate 21 Aug 2023 12:09PM $0.240 $0.150 $0.170 fallen by 37.50%
$35 Xprecia Prime tender win in Italy 9 Aug 2023 8:28AM $0.270 $0.150 $0.170 fallen by 44.44%
$35 UBI Petrackr Update 8 Aug 2023 8:28AM $0.230 $0.150 $0.170 fallen by 34.78%
$35 H1 2023 Results Webinar 2 Aug 2023 8:29AM $0.240 $0.150 $0.170 fallen by 37.50%
$35 Half Year Results Presentation - 30 June 2023 31 Jul 2023 8:49AM $0.265 $0.150 $0.170 fallen by 43.40%
$35 Appendix 4D and Half Year Results - 30 June 2023 31 Jul 2023 8:44AM $0.265 $0.150 $0.170 fallen by 43.40%
$35 June 2023 Quarterly Activity Report and Appendix 4C 28 Jul 2023 3:16PM $0.260 $0.150 $0.170 fallen by 42.31%
$35 Appendix 3Y - David Hoey 7 Jul 2023 3:21PM $0.210 $0.150 $0.170 fallen by 28.57%
$35 Xprecia Business Update 3 Jul 2023 9:21AM $0.260 $0.150 $0.170 fallen by 42.31%
$35 Results of 2023 Annual General meeting 22 May 2023 12:14PM $0.260 $0.150 $0.170 fallen by 42.31%
$35 CEO's AGM address to Securityholders 22 May 2023 8:33AM $0.230 $0.150 $0.170 fallen by 34.78%
$35 Q1 2023 Results 11 May 2023 3:41PM $0.230 $0.150 $0.170 fallen by 34.78%
$35 UBI launches PETRACKR Diabetes product for dogs and cats 3 May 2023 8:19AM $0.240 $0.150 $0.170 fallen by 37.50%
$35 Change in substantial holding 1 May 2023 2:27PM $0.250 $0.150 $0.170 fallen by 40%
$35 Notification of cessation of securities - UBI 28 Apr 2023 3:43PM $0.275 $0.150 $0.170 fallen by 45.45%
$35 March 2023 Quarterly Activity Report and Appendix 4C 28 Apr 2023 3:42PM $0.275 $0.150 $0.170 fallen by 45.45%
$35 UBI launch sixth new Sentia Test 20 Apr 2023 8:12AM $0.280 $0.150 $0.170 fallen by 46.43%
$35 Notice of Meeting/Proxy Statement 11 Apr 2023 8:15AM $0.280 $0.150 $0.170 fallen by 46.43%
$35 UBI submits Xprecia Prime 510K Application to FDA 24 Mar 2023 10:45AM $0.245 $0.150 $0.170 fallen by 38.78%
$35 Appendix 3Y - Graham McLean 16 Mar 2023 8:40AM $0.245 $0.150 $0.170 fallen by 38.78%
$35 FY2022 Corporate Governance Statement & Appendix 4G 14 Mar 2023 11:43AM $0.250 $0.150 $0.170 fallen by 40%
$35 FY2022 Corporate Governance Statement and Appendix 4G 24 Feb 2023 4:08PM $0.280 $0.150 $0.170 fallen by 46.43%
$35 UBI Investor Presentation FY2022 24 Feb 2023 4:08PM $0.280 $0.150 $0.170 fallen by 46.43%
$35 Appendix 4E and Annual Report on Form 10-K FY2022 24 Feb 2023 3:53PM $0.280 $0.150 $0.170 fallen by 46.43%
$35 UBI launch another new Sentia Test 21 Feb 2023 8:32AM $0.315 $0.150 $0.170 fallen by 52.38%

51 - 75 of 571 results

Page 3 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.